Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR6080 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928973 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM126B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929034 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HES2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDOR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2H3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF10L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on